FDA Inspection 1187520 - Royal Chemical Company - November 08, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Royal Chemical Company

Record Details

This FDA Inspection record concerns Royal Chemical Company, with an inspection on November 8, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Royal Chemical Company
Inspection Date: November 8, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · a951b09b-d004-4b6d-aff8-93371b84631e

Violation Codes8

21 CFR 211.100(a)21 CFR 211.113(a)21 CFR 211.165(d)21 CFR 211.18221 CFR 211.19221 CFR 211.22(d)21 CFR 211.67(b)21 CFR 211.84(d)(2)

Full citation text and observation details available on the Dashboard.